Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)
China
· Delayed Price · Currency is CNY 6.27
+0.07 (1.13%)
At close: Mar 10, 2026
Beijing SL Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 383.95 | 411.96 | 683.83 | 595.04 | 827.84 | 663.48 | Upgrade
|
| Short-Term Investments | - | 1,089 | 840.62 | 713.36 | 646.23 | 605.63 | Upgrade
|
| Trading Asset Securities | 569.63 | 480.86 | 608.56 | 144.91 | 162.36 | 173.81 | Upgrade
|
| Cash & Short-Term Investments | 953.57 | 1,982 | 2,133 | 1,453 | 1,636 | 1,443 | Upgrade
|
| Cash Growth | 3.52% | -7.07% | 46.77% | -11.19% | 13.41% | -24.62% | Upgrade
|
| Accounts Receivable | 90.66 | 105.79 | 200.57 | 254.86 | 357.56 | 466.08 | Upgrade
|
| Other Receivables | 14.91 | 15.65 | 35.25 | 31.35 | 21.6 | 2.9 | Upgrade
|
| Receivables | 105.56 | 121.44 | 235.82 | 286.2 | 379.16 | 468.98 | Upgrade
|
| Inventory | 394.81 | 246.33 | 144.46 | 136.82 | 124.83 | 112.03 | Upgrade
|
| Other Current Assets | 1,132 | 138.8 | 126.69 | 121.34 | 157.31 | 183.4 | Upgrade
|
| Total Current Assets | 2,586 | 2,489 | 2,640 | 1,998 | 2,298 | 2,207 | Upgrade
|
| Property, Plant & Equipment | 533.23 | 514.24 | 503.34 | 527.3 | 604.01 | 589.16 | Upgrade
|
| Long-Term Investments | 1,222 | 1,578 | 1,573 | 1,798 | 1,404 | 1,251 | Upgrade
|
| Other Intangible Assets | 683.98 | 678.58 | 693.77 | 526.36 | 479.46 | 423.38 | Upgrade
|
| Long-Term Deferred Tax Assets | 64.08 | 69.52 | - | 39.5 | 27.65 | 25.35 | Upgrade
|
| Long-Term Deferred Charges | 489.85 | 519 | 451.89 | 454.42 | 394.72 | 291.84 | Upgrade
|
| Other Long-Term Assets | 449.13 | 130.49 | 415.6 | 532.22 | 553.25 | 606.28 | Upgrade
|
| Total Assets | 6,029 | 5,979 | 6,278 | 5,876 | 5,760 | 5,395 | Upgrade
|
| Accounts Payable | 55.35 | 122.29 | 250.76 | 176.18 | 191.4 | 179.93 | Upgrade
|
| Accrued Expenses | 36.57 | 45.82 | 46.93 | 30.32 | 31.8 | 25.23 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 5.51 | Upgrade
|
| Current Portion of Leases | - | - | - | - | 0.25 | - | Upgrade
|
| Current Income Taxes Payable | 2.07 | 0.18 | 0 | 2.61 | 4.48 | 4.28 | Upgrade
|
| Current Unearned Revenue | 75.6 | 70.53 | 15.29 | 27.87 | 13.33 | 10.01 | Upgrade
|
| Other Current Liabilities | 39.46 | 50.59 | 60.34 | 51.85 | 83.71 | 90.02 | Upgrade
|
| Total Current Liabilities | 209.04 | 289.41 | 373.33 | 288.83 | 324.96 | 314.98 | Upgrade
|
| Long-Term Leases | - | - | - | - | 2.22 | - | Upgrade
|
| Long-Term Unearned Revenue | 41.17 | 44 | 47.04 | 51.38 | 56.23 | 60.97 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 77.75 | 64.97 | 47.36 | 56.39 | 50.82 | 34.15 | Upgrade
|
| Total Liabilities | 327.96 | 398.37 | 467.72 | 396.6 | 434.23 | 410.09 | Upgrade
|
| Common Stock | 1,027 | 1,027 | 1,027 | 1,027 | 1,027 | 1,027 | Upgrade
|
| Additional Paid-In Capital | 49.62 | 49.62 | 49.62 | 43.85 | 32.58 | 17.59 | Upgrade
|
| Retained Earnings | 4,603 | 4,482 | 4,710 | 4,396 | 4,265 | 3,941 | Upgrade
|
| Comprehensive Income & Other | 13.47 | 13.47 | 13.47 | 0.67 | -12.99 | -11.68 | Upgrade
|
| Total Common Equity | 5,693 | 5,572 | 5,801 | 5,468 | 5,311 | 4,975 | Upgrade
|
| Minority Interest | 7.73 | 8.2 | 9.42 | 11.16 | 14.73 | 10.13 | Upgrade
|
| Shareholders' Equity | 5,701 | 5,581 | 5,810 | 5,479 | 5,326 | 4,985 | Upgrade
|
| Total Liabilities & Equity | 6,029 | 5,979 | 6,278 | 5,876 | 5,760 | 5,395 | Upgrade
|
| Total Debt | - | - | - | - | 2.47 | 5.51 | Upgrade
|
| Net Cash (Debt) | 953.57 | 1,982 | 2,133 | 1,453 | 1,634 | 1,437 | Upgrade
|
| Net Cash Growth | 3.52% | -7.07% | 46.77% | -11.06% | 13.67% | -24.75% | Upgrade
|
| Net Cash Per Share | 0.90 | 1.87 | 2.10 | 1.43 | 1.57 | 1.42 | Upgrade
|
| Filing Date Shares Outstanding | 1,027 | 1,027 | 1,027 | 1,027 | 1,027 | 1,027 | Upgrade
|
| Total Common Shares Outstanding | 1,027 | 1,027 | 1,027 | 1,027 | 1,027 | 1,027 | Upgrade
|
| Working Capital | 2,377 | 2,199 | 2,267 | 1,709 | 1,973 | 1,892 | Upgrade
|
| Book Value Per Share | 5.54 | 5.42 | 5.65 | 5.32 | 5.17 | 4.84 | Upgrade
|
| Tangible Book Value | 5,009 | 4,894 | 5,107 | 4,942 | 4,832 | 4,551 | Upgrade
|
| Tangible Book Value Per Share | 4.88 | 4.76 | 4.97 | 4.81 | 4.70 | 4.43 | Upgrade
|
| Buildings | - | 434.54 | 437.22 | 430.73 | 452.32 | 457.05 | Upgrade
|
| Machinery | - | 472.98 | 458.48 | 435.39 | 415.76 | 388.59 | Upgrade
|
| Construction In Progress | - | 94.92 | 56.97 | 64.75 | 99.87 | 67.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.